iShares Evolved U.S. Innovative Healthcare ETF NASDAQ:IEIH

iShares Evolved U.S. Innovative Healthcare ETF stock price today

$34.135
Financial Health
0
1
2
3
4
5
6
7
8
9

iShares Evolved U.S. Innovative Healthcare ETF stock price monthly change

+2.52%
month

iShares Evolved U.S. Innovative Healthcare ETF stock price quarterly change

+4.74%
quarter

iShares Evolved U.S. Innovative Healthcare ETF stock price yearly change

-9.19%
year

iShares Evolved U.S. Innovative Healthcare ETF key metrics

Market Cap
N/A
Enterprise value
N/A
P/E
N/A
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
N/A
PEG ratio
N/A
EPS
1.46
Revenue
418.71M
EBITDA
389.65M
Income
172.52M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
93.06%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

iShares Evolved U.S. Innovative Healthcare ETF stock price history

iShares Evolved U.S. Innovative Healthcare ETF stock forecast

iShares Evolved U.S. Innovative Healthcare ETF financial statements

iShares Evolved U.S. Innovative Healthcare ETF (NASDAQ:IEIH): Profit margin
Mar 2013 101.76M 38.12M 37.46%
Jun 2013 102.51M 49.05M 47.85%
Sep 2013 103.30M 38.13M 36.92%
Dec 2013 111.13M 47.20M 42.48%
2.41%
Yield TTM
iShares Evolved U.S. Innovative Healthcare ETF (NASDAQ:IEIH): Payout ratio
Payout ratio 0%
iShares Evolved U.S. Innovative Healthcare ETF (NASDAQ:IEIH): Dividend Yield
2013 7.63%
iShares Evolved U.S. Innovative Healthcare ETF (NASDAQ:IEIH): Debt to assets
Mar 2013 3004641000 1.89B 63.2%
Jun 2013 2979796000 1.84B 61.83%
Sep 2013 3014778000 1.82B 60.53%
Dec 2013 3462216000 2.16B 62.45%
iShares Evolved U.S. Innovative Healthcare ETF (NASDAQ:IEIH): Cash Flow
Mar 2013 57.6M -11.45M -22.24M
Jun 2013 63.72M -33.50M -48.79M
Sep 2013 78.72M -24.83M 6.83M
Dec 2013 79.89M -529.03M 383.99M

iShares Evolved U.S. Innovative Healthcare ETF other data

Wednesday, 20 July 2022
Zacks Investment Research
Friday, 8 July 2022
Zacks Investment Research
Tuesday, 21 June 2022
ETFcom
Wednesday, 16 March 2022
Zacks Investment Research
Friday, 17 December 2021
Zacks Investment Research
Saturday, 2 October 2021
Zacks Investment Research
  • What's the price of iShares Evolved U.S. Innovative Healthcare ETF stock today?

    One share of iShares Evolved U.S. Innovative Healthcare ETF stock can currently be purchased for approximately $34.13.

  • When is iShares Evolved U.S. Innovative Healthcare ETF's next earnings date?

    Unfortunately, iShares Evolved U.S. Innovative Healthcare ETF's (IEIH) next earnings date is currently unknown.

  • Does iShares Evolved U.S. Innovative Healthcare ETF pay dividends?

    Yes, iShares Evolved U.S. Innovative Healthcare ETF pays dividends and its trailing 12-month yield is 2.41% with 0% payout ratio. The last iShares Evolved U.S. Innovative Healthcare ETF stock dividend of $0.51 was paid on 7 Sep 2025.

  • What is iShares Evolved U.S. Innovative Healthcare ETF's stock symbol?

    iShares Evolved U.S. Innovative Healthcare ETF is traded on the NASDAQ under the ticker symbol "IEIH".

  • How do i buy shares of iShares Evolved U.S. Innovative Healthcare ETF?

    Shares of iShares Evolved U.S. Innovative Healthcare ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When iShares Evolved U.S. Innovative Healthcare ETF went public?

    iShares Evolved U.S. Innovative Healthcare ETF is publicly traded company for more then 7 years since IPO on 21 Mar 2018.

  • How can i contact iShares Evolved U.S. Innovative Healthcare ETF?

    iShares Evolved U.S. Innovative Healthcare ETF can be reached via phone at +800 4742737.

iShares Evolved U.S. Innovative Healthcare ETF company profile:

iShares Evolved U.S. Innovative Healthcare ETF

Exchange:

NASDAQ

Full time employees:

0

Industry:

Sector:

The fund invests, under normal circumstances, at least 80% of its net assets in U.S. listed common stock of large-, mid- and small-capitalization pharmaceutical and biotechnology companies. It will hold common stock of those companies that fall into the Innovative Healthcare Evolved Sector which have economic characteristics that have been historically correlated with companies traditionally defined as pharmaceutical and biotechnology companies. The fund is non-diversified.

:
ISIN: US46431W6223
: